Starving Tumors on a Chip: Glucose and Oxygen Steer Cancer Growth

Cancer is not just a matter of rogue cells dividing uncontrollably; it is a story of survival under siege, played out in the cramped, nutrient-starved depths of a growing tumor. Now, researchers at the University of Zaragoza in Spain have built a miniature laboratory that lets them watch that drama unfold in real time, one glucose molecule and one oxygen atom at a time. Writing in the Annals of Biomedical Engineering, Paula Guerrero-López and Jose Manuel Garcia-Aznar describe a microfluidic 3D model in which lung adenocarcinoma spheroids grow inside a collagen matrix while the team systematically manipulates the availability of glucose, glutamine, and oxygen. The results reveal, with striking clarity, that each of these metabolic inputs leaves its own distinct fingerprint on tumor growth, architecture, and stress signaling.

The platform itself is a feat of miniaturization. Fabricated from polydimethylsiloxane, the chip features a central culture chamber measuring just 2.5 by 1.3 millimeters, flanked by two lateral media channels. Into the chamber, the researchers injected a hydrogel of type I collagen at 6 milligrams per milliliter, seeded with human A549 lung adenocarcinoma cells at a density of 0.2 million cells per milliliter. Rather than pre-assembling spheroids and transferring them into the device, the team allowed the aggregates to form spontaneously within the matrix, guided entirely by microenvironmental conditions. This approach mimics a key aspect of early tumorigenesis, where isolated cells must organize themselves into multicellular structures before they can exploit the cooperative behaviors that make tumors dangerous.

Before perturbing the system, the researchers first characterized how glucose and oxygen behave inside the chip. By filling one lateral channel with high-glucose medium at 4.5 grams per liter and the other with glucose-free medium, they established a controlled gradient across the hydrogel. Glucose was detectable in the previously empty channel within 24 hours, and full equilibration between the two sides took about 48 hours, confirming that the collagen gel permits predictable diffusion. Oxygen, monitored with a fiber-optic dissolved oxygen probe at the channel inlets, drifted from roughly 10 parts per million down to a stable plateau near 7.5 parts per million over the first two days, a pattern that proved essentially identical whether cells were present or not. In other words, the chip’s intrinsic diffusion dynamics, rather than cellular consumption, dominate the oxygen profile at the device level, a detail the authors note as an important caveat when interpreting oxygen availability at the spheroid itself.

With the platform validated, the team launched a multifactorial experiment testing all eight combinations of glucose presence, glutamine presence, and normoxia or hypoxia. The outcome was unambiguous: glutamine is non-negotiable. When glutamine was removed, near-complete loss of cellular structures followed regardless of what else was available, and no spheroid-like formations could be detected by day 9. This aligns with a substantial body of literature showing that glutamine serves as a critical carbon and nitrogen source for biosynthesis, anaplerosis, and redox balance, and that blocking glutamine metabolism triggers apoptosis. Intriguingly, under hypoxia induced by sealing the chips with parafilm, some residual cellular growth persisted even without glutamine, hinting at a partial compensatory effect of low oxygen that the authors suggest may involve the exploitation of alternative metabolic routes, such as collagen-derived proline, though this proved insufficient to rescue full viability.

Glucose told a subtler and, in places, counterintuitive story. Spheroids deprived of glucose from the outset grew poorly, and withdrawing glucose at day 5 from cultures previously grown in low-glucose medium caused a marked arrest in growth. Yet, surprisingly, spheroids cultured continuously in low glucose at 1 gram per liter under normal oxygen levels grew faster than their high-glucose counterparts, a statistically significant difference. The authors attribute this to the known toxicity of elevated glucose concentrations, which can drive oxidative stress through reactive oxygen species production, glucose auto-oxidation, and the formation of advanced glycation end-products, alongside a hyperosmotic environment that disrupts proliferation and cytoskeletal organization. Under chemically induced hypoxia, however, the hierarchy flipped: spheroids in high glucose grew best, consistent with hypoxia-driven metabolic rewiring that upregulates glucose transporters and favors glycolytic flux.

The hypoxia signaling itself proved more nuanced than a simple oxygen meter. Using immunofluorescence for hypoxia-inducible factor 1-alpha, or HIF-1α, the researchers found that the only condition showing virtually no expression was normoxia with abundant glucose and glutamine, the metabolically comfortable state. But nutrient deprivation alone, even with normal oxygen, strongly induced HIF-1α, with the highest signals concentrated in the spheroid core and, under glutamine starvation, the strongest overall expression of all. Pimonidazole staining, which marks genuinely hypoxic tissue, revealed that these HIF-1α signals did not always track actual oxygen tension. The authors conclude that HIF-1α should be read as a marker of hypoxia-related signaling and metabolic adaptation rather than a direct proxy for local oxygen levels, a distinction with real consequences for how hypoxia is measured in cancer studies.

Perhaps the most visually compelling findings came from the structural analysis. Using confocal microscopy and 3D reconstructions from lattice light-sheet imaging, the team quantified actin organization, nuclear distribution, sphericity, and nearest-neighbor distances between nuclei. Well-fed spheroids in high glucose under normoxia were compact and beautifully layered, with a dense outer actin capsule, a proliferative periphery, and stable cellular protrusions extending into the matrix. Glucose withdrawal at day 5 dissolved those protrusions and spawned actin-rich knots in the interior, while chronic glucose absence produced spheroids that retained an outer shell but lost all internal organization, in some cases developing cavities at their cores. Remarkably, the external shape, captured by the sphericity metric, remained largely unchanged across glucose conditions, meaning that a tumor can look perfectly spherical from the outside while being hollowed out within.

Oxygen deprivation, by contrast, acted primarily on architecture rather than size. When hypoxia was induced at day 5, either chemically with ciclopirox olamine, a hypoxia mimetic that stabilizes HIF-1α, or physically by parafilm sealing, spheroids in high glucose showed no growth differences but suffered clear structural damage: loss of the peripheral actin capsule, reduced nuclear density at the rim, enlarged gaps between neighboring nuclei, and frequent internal cavities. Under glucose-free conditions, the combination proved devastating, with oxygen-depleted spheroids showing strong growth arrest and the most severe disorganization, including hollow, organoid-like structures. The authors interpret these cavities as most likely reflecting central necrosis or cell death, since live-dead staining showed spatial correspondence with ethidium homodimer-positive regions, though they caution that 2D imaging cannot definitively distinguish necrosis, apoptosis, or dysregulated autophagy as the underlying mechanism.

One finding carries particular therapeutic weight: when the researchers reintroduced depleted nutrients after prolonged deprivation, spheroids failed to resume normal growth, continuing to expand at the same suppressed rate for at least three days afterward. This suggests a form of metabolic memory, in which sustained nutrient stress leaves persistent adaptations, irreversible damage, or selected subpopulations that resist recovery. If such memory operates in real tumors, transient metabolic interventions could produce long-lasting suppression of tumor behavior well beyond the treatment window. The study has limitations the authors openly acknowledge, including reliance on a single cell line, the technical difficulty of measuring oxygen directly in the central chamber, and the low throughput inherent to sophisticated organ-on-chip systems. Yet the reproducibility of the trends across independent experiments and the platform’s demonstrated versatility with other cancer types in prior work suggest a robust foundation. As microfluidic tumor models mature, this chip offers something static cultures cannot: a dynamic, spatially resolved window into how tumors negotiate their metabolic environment, and a roadmap for exploiting the vulnerabilities that negotiation exposes.

Subject of Research: Effects of glucose, glutamine, and oxygen availability on the growth and architecture of lung adenocarcinoma spheroids in a microfluidic 3D collagen model

Article Title: Glucose and Oxygen Availability Shape Growth and Architecture of Tumor Spheroids in a Microfluidic 3D Model

Article References: Guerrero-López, P., & Garcia-Aznar, J. M. (2026). Glucose and Oxygen Availability Shape Growth and Architecture of Tumor Spheroids in a Microfluidic 3D Model. Annals of Biomedical Engineering. https://doi.org/10.1007/s10439-026-04377-2

Image Credits: AI Generated

DOI: 10.1007/s10439-026-04377-2

Keywords: tumor spheroids, microfluidics, cancer metabolism, glucose depletion, hypoxia, HIF-1α, glutamine, 3D cell culture, tumor microenvironment, lung adenocarcinoma, collagen hydrogel, organ-on-chip